CRBU
Caribou Biosciences Inc

2,694
Mkt Cap
$152.35M
Volume
1.36M
52W High
$3.54
52W Low
$0.66
PE Ratio
-0.96
CRBU Fundamentals
Price
$1.57
Prev Close
$1.63
Open
$1.63
50D MA
$1.66
Beta
1.87
Avg. Volume
1.05M
EPS (Annual)
-$1.65
P/B
1.07
Rev/Employee
$67,986.40
$39.43
Loading...
Loading...
News
all
press releases
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?
Here is how Biohaven Ltd. (BHVN) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Zacks·12h ago
News Placeholder
More News
News Placeholder
What is Brookline Cap M's Forecast for CRBU FY2030 Earnings?
Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Brookline Cap M issued their FY2030 earnings per share estimates for Caribou Biosciences in a report released on...
MarketBeat·4d ago
News Placeholder
Research Analysts Offer Predictions for CRBU FY2030 Earnings
Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities research analysts at Brookline Capital Management issued their FY2030 earnings per share (EPS) estimates for Caribou Biosciences in a...
MarketBeat·5d ago
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Shares Up 3.8% - What's Next?
Caribou Biosciences (NASDAQ:CRBU) Stock Price Up 3.8% - Should You Buy...
MarketBeat·6d ago
News Placeholder
Caribou Biosciences (CRBU) Upgraded to Buy: Here's Why
Caribou Biosciences (CRBU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·28d ago
News Placeholder
Cathie Wood shells out $1.3 million on biotech stock
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it...
TheStreet.com·1mo ago
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Trading Up 2.4% - Should You Buy?
Caribou Biosciences (NASDAQ:CRBU) Trading 2.4% Higher - Here's Why...
MarketBeat·2mo ago
News Placeholder
Caribou Biosciences Target of Unusually Large Options Trading (NASDAQ:CRBU)
Caribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) was the recipient of some unusual options trading on Monday. Investors purchased 2,867 call options on the stock. This represents an increase...
MarketBeat·2mo ago
News Placeholder
Caribou Biosciences, Inc. $CRBU Shares Bought by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. increased its stake in Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 626.8% in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·2mo ago
News Placeholder
Caribou Biosciences (NASDAQ:CRBU) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS
Caribou Biosciences (NASDAQ:CRBU - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.30) earnings per share (EPS) for the quarter, beating analysts' consensus...
MarketBeat·3mo ago
<
1
2
...
>

Latest CRBU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.